- Monday, August 24, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Neuromodulation Market by Technology (Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's disease, Obsessive-Compulsive Disorder, Migraine) and Biomaterial (Metallic, Polymeric, Ceramic) and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa).
Global Neuromodulation Market Overview:
Neuromodulation is a science, medicine, and bioengineering field that bound implantable and non-implantable technologies, electrical or chemical, to improve humans’ quality of life and functioning. It is the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. It is carried out to normalize or modulate nervous tissue function. In other words, Neuromodulation works by either actively stimulating nerves to introduce a natural biological response or by applying/taking targeted pharmaceutical agents in tiny doses directly to the site of action. Neuromodulation devices and treatments are available to treat nearly every disease or symptom, from headaches to tremors to spinal cord damage to urinary incontinence. Also, conditions that can be treated with neuromodulation are chronic pain, movement disorders, epilepsy, Psychiatric Disorders, functional restoration, cardiovascular disorders, gastrointestinal disorders, emerging indications, and spinal cord injury.
Global Neuromodulation Market Insights
Global neuromodulation market size is projected to grow at a CAGR of over 14.58% during 2020–2027. The patient of the market can be attributed to rising incidences of chronic illness and increasing neurological disorders. Further, the increasing chronic conditions such as chronic back pain, depression, epilepsy & sleep apnea has led to a shift in the focus of the health care provider to neuro stimulation techniques for the treatment of these diseases, which is anticipated to fuel the demand for neuromodulation across the globe in the coming years. Additionally, market players’ advent in technology and advanced neuromodulation devices are strengthening the market growth. Moreover, the surge in popularity of neuromodulation is due to zero impacts associated with more systemic or irreversible treatments of nervous system disorders, is expected to witness remarkable growth of the neuromodulation industry. The new indication and increasing target applications are driving the growth of the market.
Furthermore, the increasing awareness regarding the safety and efficacy of neurostimulators and rising government investments in the health care industry are positively impacting the demand for neuromodulation in the future. Neuromodulation devices have progressed, becoming more cost-effective, smaller, more easily implanted and removed, and more highly targeted will boom the market growth in the estimated periods. Promising new neuromodulation therapies address diverse disorders such as migraine, obesity, obsessive-compulsive disorder, and depression and are truly multidisciplinary, requiring the close collaboration of neuroscientists, engineers, clinicians, neuroscientists, and engineers to reach fruition will promulgate the global neuromodulation market share.
Growth Driver
Neuromodulation is a cost-effective and easily implanted technique for managing chronic pains. It can reduce office and emergency room visits, hospitalizations, ineffective or risky surgical procedures, and misuse of opioid medications. Neuromodulation treatments have typically been served to patients only after having tried relevant treatment way such as medications, physical and occupational therapy, or surgery. Neuromodulation modalities are promising therapies when ongoing treatment becomes problematic for long-term use due to the development of tolerance, addiction, & adverse negative impacts. These are minimally invasive procedures that have a good potential to enhance patients’ lives.
Technology Segmental Analysis
Based on technology, the global neuromodulation market is classified into internal and external neuromodulation. Internal neuromodulation is further divided into Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation. Furthermore, external neuromodulation is divided into Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), and Respiratory Electrical Stimulation (RES). The internal neuromodulation segment accounted for the highest market share in 2019. It is attributable to its reversibility, more cost-effectiveness, and reduction in post-surgical complications.
The external TENS segment will garner a significant market share in the forecast period. It is owing to the increasing incidence of chronic conditions, rising demand for non-invasive therapy, and cost-effectivity.
Application Segmental Analysis
Based on the application, the global neuromodulation market is segregated into chronic pain management, failed back syndrome, epilepsy, tremor, urinary &fecal incontinence, depression, dystonia, gastroparesis, Parkinson’s disease, obsessive-compulsive disorder, migraine, and other applications.
The chronic pain management segment held a higher revenue share in 2019 and is projected to dominate the neuromodulation market by 2027. It is primarily attributed to the efficiency of neuro stimulation devices to treat chronic pain like back pain, and it is more safe & reversible therapy.
The Neurological disorders segment will grow with a lucrative growth rate in the forecast period. It is due to increasing diseases such as epilepsy, depression, psychiatry disorders & others and rising needs for adaptation.
Region Segmental Analysis
The global neuromodulation market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is to account for a significant share by 2027 in the neuromodulation market. The growth in the region can be attributed to the growing importance of neuromodulation devices to treat chronic diseases, increasing development in healthcare infrastructure, and growing government approvals for non-invasive devices.
The Asia Pacific is expected to provide significant growth opportunities due to improving the health care industry, improving diagnosis & treatment rates, and rising government expenditure.
Competitor Analysis
Companies such as Abbott, Bluewind Medical, Boston Scientific Corporation, Biocontrol Medical, Bioness, Bioinduction, Gimer Medical, GTX Medical, Helius Medical Technologies, Integer Holdings Corporation, Medtronic, Livanova, Nevro Corporation, NeurosigmaInc, NeuropaceInc, Synapse Biomedical, Neuronetics, Soterix Medical, Neuronano, and Microtransponder are the key players in the global neuromodulation market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global neuromodulation technology manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to neuromodulation
- Regulatory bodies
- Suppliers
- Retailers
The objective of the Research
- Market modeling begins with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation (RES)
By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Global Neuromodulation Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global Neuromodulation Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- Internal neuromodulation
- By Technology
- Market Size & Forecast,2016-2027
- North America Neuromodulation Market Overview
- North America Neuromodulation Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America Neuromodulation Market Share & Forecast,2016-2027
- By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Neuromodulation Market
- Internal neuromodulation
- By Technology
- North America Neuromodulation Market Size & Forecast, 2016-2027
- Europe Neuromodulation Market Overview
- Europe Neuromodulation Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe Neuromodulation Market Share & Forecast,2016-2027
- By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Neuromodulation Market
- Internal neuromodulation
- By Technology
- Europe Neuromodulation Market Size & Forecast, 2016-2027
- Asia Pacific Neuromodulation Market Overview
- Asia Pacific Neuromodulation Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific Neuromodulation Market Share & Forecast, 2016-2027
- By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulatio
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Neuromodulation Market
- Internal neuromodulation
- By Technology
- Asia Pacific Neuromodulation Market Size & Forecast, 2016-2027
- South America Neuromodulation Market Overview
- South America Neuromodulation Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America Neuromodulation Market Share & Forecast,2016-2027
- By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Neuromodulation Market
- Internal neuromodulation
- By Technology
- South America Neuromodulation Market Size & Forecast, 2016-2027
- Middle East & Africa Neuromodulation Market Overview
- Middle East & Africa Neuromodulation Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Middle East & Africa Neuromodulation Market Share & Forecast, 2016-2027
- By Technology
- Internal neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Other Neuromodulation Technologies
- External neuromodulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
- By Application
- Chronic Pain Management
- Depression
- Dystonia
- Migraine
- Epilepsy
- Failed back syndrome
- Tremor
- Urinary and Fecal Incontinence
- Gastroparesis
- Parkinson’s disease
- Obsessive-Compulsive Disorder
- Other Applications
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Neuromodulation Market
- Internal neuromodulation
- By Technology
- Middle East & Africa Neuromodulation Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Abbott
- Bluewind Medical
- Boston Scientific Corporation
- Biocontrol Medical
- Bioness
- Bioinduction
- Gimer Medical
- GTX Medical
- Helius Medical Technologies
- Integer Holdings Corporation
- Medtronic
- Livanova
- Nevro Corporation
- Neurosigma Inc
- Neuropace Inc
- Synapse Biomedical
- Neuronetics
- Soterix Medical
- Neuronano
- Microtransponder
